123 related articles for article (PubMed ID: 20194252)
21. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
22. Retrospective review of pediatric patients with acute lymphoblastic leukemia: a single center experience.
Khalid S; Moiz B; Adil SN; Khurshid M
Indian J Pathol Microbiol; 2010; 53(4):704-10. PubMed ID: 21045397
[TBL] [Abstract][Full Text] [Related]
23. A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers.
Downs-Canner S; Shaw PH
J Pediatr Hematol Oncol; 2009 Dec; 31(12):927-9. PubMed ID: 19855302
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area.
Howard SC; Pedrosa M; Lins M; Pedrosa A; Pui CH; Ribeiro RC; Pedrosa F
JAMA; 2004 May; 291(20):2471-5. PubMed ID: 15161898
[TBL] [Abstract][Full Text] [Related]
25. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.
Shaw PH; Boyiadzis M; Tawbi H; Welsh A; Kemerer A; Davidson NE; Ritchey AK
Cancer; 2012 Jul; 118(14):3614-7. PubMed ID: 22213134
[TBL] [Abstract][Full Text] [Related]
26. Association of clinical trial enrollment and survival using contemporary therapy for pediatric acute lymphoblastic leukemia.
Moke DJ; Oberley MJ; Bhojwani D; Parekh C; Orgel E
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28876513
[TBL] [Abstract][Full Text] [Related]
27. Weekend delay in initiation of chemotherapy for acute lymphoblastic leukemia: does it matter?
Wahl SK; Gildengorin G; Feusner J
J Pediatr Hematol Oncol; 2012 Jan; 34(1):e8-e11. PubMed ID: 22146528
[TBL] [Abstract][Full Text] [Related]
28. Insidious iron burden in pediatric patients with acute lymphoblastic leukemia.
Eng J; Fish JD
Pediatr Blood Cancer; 2011 Mar; 56(3):368-71. PubMed ID: 21072815
[TBL] [Abstract][Full Text] [Related]
29. Different rates of clinical trial enrollment between adolescents and young adults aged 15 to 22 years old and children under 15 years old with cancer at a children's hospital.
Shaw PH; Ritchey AK
J Pediatr Hematol Oncol; 2007 Dec; 29(12):811-4. PubMed ID: 18090927
[TBL] [Abstract][Full Text] [Related]
30. Influence of length of time to diagnosis and treatment on the survival of children with acute lymphoblastic leukemia: a population-based study.
Baker JM; To T; Beyene J; Zagorski B; Greenberg ML; Sung L
Leuk Res; 2014 Feb; 38(2):204-9. PubMed ID: 24333116
[TBL] [Abstract][Full Text] [Related]
31. Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
Meeske KA; Ji L; Freyer DR; Gaynon P; Ruccione K; Butturini A; Avramis VI; Siegel S; Matloub Y; Seibel NL; Sposto R
Pediatr Blood Cancer; 2015 Dec; 62(12):2140-9. PubMed ID: 26173904
[TBL] [Abstract][Full Text] [Related]
32. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.
Nguyen K; Devidas M; Cheng SC; La M; Raetz EA; Carroll WL; Winick NJ; Hunger SP; Gaynon PS; Loh ML;
Leukemia; 2008 Dec; 22(12):2142-50. PubMed ID: 18818707
[TBL] [Abstract][Full Text] [Related]
33. Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment.
Wolfson JA; Richman JS; Sun CL; Landier W; Leung K; Smith EP; O'Donnell M; Bhatia S
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1133-1141. PubMed ID: 30262597
[No Abstract] [Full Text] [Related]
34. Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study.
Strahlendorf C; Pole JD; Barber R; Dix D; Kulkarni K; Martineau E; Randall A; Stammers D; Strother D; Truong TH; Sung L
Br J Cancer; 2018 Mar; 118(5):744-749. PubMed ID: 29381687
[TBL] [Abstract][Full Text] [Related]
35. Feasibility and parent satisfaction of a physical therapy intervention program for children with acute lymphoblastic leukemia in the first 6 months of medical treatment.
Gohar SF; Comito M; Price J; Marchese V
Pediatr Blood Cancer; 2011 May; 56(5):799-804. PubMed ID: 21370414
[TBL] [Abstract][Full Text] [Related]
36. Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review.
Pritchard MT; Butow PN; Stevens MM; Duley JA
J Pediatr Hematol Oncol; 2006 Dec; 28(12):816-23. PubMed ID: 17164651
[TBL] [Abstract][Full Text] [Related]
37. Socioeconomic status and event free survival in pediatric acute lymphoblastic leukemia: a population-based cohort study.
Gupta S; Sutradhar R; Guttmann A; Sung L; Pole JD
Leuk Res; 2014 Dec; 38(12):1407-12. PubMed ID: 25224660
[TBL] [Abstract][Full Text] [Related]
38. Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.
Aristizabal P; Singer J; Cooper R; Wells KJ; Nodora J; Milburn M; Gahagan S; Schiff DE; Martinez ME
Pediatr Blood Cancer; 2015 Aug; 62(8):1337-44. PubMed ID: 25755225
[TBL] [Abstract][Full Text] [Related]
39. Altruistic discourse in the informed consent process for childhood cancer clinical trials.
Simon C; Eder M; Kodish E; Siminoff L
Am J Bioeth; 2006; 6(5):40-7. PubMed ID: 16997825
[TBL] [Abstract][Full Text] [Related]
40. Treatment of T cell lymphoblastic lymphoma in children and adolescents: Israel Society of Pediatric Hematology Oncology retrospective study.
Katz OB; Ben Barak A; Abrahami G; Arad N; Burstein Y; Dvir R; Fischer S; Kapelushnik J; Kaplinsky H; Toren A; Vilk-Revel S; Weintraub M; Yaniv I; Linn S; Futerman B; Ben-Arush MW
Isr Med Assoc J; 2011 Mar; 13(3):161-5. PubMed ID: 21608337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
